{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Rate of growth of the composite (total) treated volume (up to four sites) compared to the composite volume of up to four newly identified and untreated prospectively-identified (at the time of systemic progression) metastatic sites. Volume doubling time will be calculated assuming an exponential growth pattern.","groups":[{"description":"Patients undergo hypofractionated highly conformal radiotherapy with helical tomotherapy once every other day over 5 days for a total of 3 fractions.","id":"OG000","title":"Radiation Therapy in Metastatic Cancer"}],"populationDescription":"No data/specimens were collected. Study was terminated due to poor accrual.","reportingStatus":"POSTED","timeFrame":"Baseline and prior to termination of systemic therapy or protocol withdrawal","title":"Tumor Doubling Times During Systemic Treatment Compared Between Tumors Untreated With Radiation (Newly Developed Tumors) and Tumors Which Have Received Radiation Therapy","type":"SECONDARY"}